Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. company information, Employees & Contact Information

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.

Company Details

Employees
60
Founded
-
Address
701 Lee Rd, Wayne,pennsylvania 19087,united States
Phone
(484) 324-7933
Email
in****@****stx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Wayne, Pennsylvania
Looking for a particular Aclaris Therapeutics, Inc. employee's phone or email?

Aclaris Therapeutics, Inc. Questions

News

Aclaris Therapeutics to Participate in Two September Healthcare Conferences - Investing News Network

Aclaris Therapeutics to Participate in Two September Healthcare Conferences Investing News Network

Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer - GlobeNewswire

Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer GlobeNewswire

Aclaris Therapeutics to Participate in Two September Healthcare Conferences - GlobeNewswire

Aclaris Therapeutics to Participate in Two September Healthcare Conferences GlobeNewswire

Aclaris Therapeutics Announces Positive Results from Phase 1 Multiple Ascending Dose Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor - Stock Titan

Aclaris Therapeutics Announces Positive Results from Phase 1 Multiple Ascending Dose Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor Stock Titan

Aclaris Therapeutics Appoints Robert Doody as Vice President - citybiz

Aclaris Therapeutics Appoints Robert Doody as Vice President citybiz

Aclaris Therapeutics to Host In-Person and Webcast R&D Day, - GlobeNewswire

Aclaris Therapeutics to Host In-Person and Webcast R&D Day, GlobeNewswire

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series - GlobeNewswire

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series GlobeNewswire

Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes - GlobeNewswire

Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire

Top Aclaris Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant